In accordance, IFNg, released by Th1 cells, was shown to increase microglial activation, amyloid beta deposition and led to impaired cognitive function in the amyloid precursor protein/presenilin 1 (APP/PS1) AD mouse model [76]. The gene discussed is IFNG; the disease is Alzheimer disease.